Phase II study of irinotecan+5FU/FA for patients with previously treated advanced gastric cancer.

被引：0
|
作者：
Peeters, M
Van Laethem, JL
Baert, F
Canon, JL
De Grève, J
Kalantari, H
Dhont, P
Van Cutsem, E
机构：
[1] State Univ Ghent Hosp, B-9000 Ghent, Belgium
[2] Erasme Univ Hosp, B-1070 Brussels, Belgium
[3] H Hart Hosp, Roeselare, Belgium
[4] Clin Notre Dame, Charleroi, Belgium
[5] Univ Brussels, Acad Ziekenhuis, Ghent, Belgium
[6] Ctr Hosp Peltzer La Tourelle, Verviers, Belgium
[7] Aventis Pharma, Brussels, Belgium
[8] Katholieke Univ Leuven, Hosp Gasthuisberg, Louvain, Belgium
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4076
引用
收藏
页码：332S / 332S
页数：1
相关论文
共 50 条
  • [41] A phase II study of oxaliplatin with ELF regimen in patients with advanced gastric cancer.
    Pan, HM
    Zhu, N
    Lou, F
    Guo, Y
    Jin, W
    Lou, HZ
    Zheng, Y
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 364S - 364S
  • [42] Phase II study of irinotecan (CPT 11) in patients whit not pretreated advanced colorectal cancer.
    Salgado, M
    Menéndez, D
    Sabin, P
    Diz, P
    Constenia-Figueiras, M
    Casai, J
    Calvo, L
    Castellanos, J
    Balcells, M
    Firvida, JL
    Irigoyen, A
    Quintero, G
    Garcia-Palomo, A
    García-Arroyo, FR
    Huidobro, G
    Valladares, M
    Garcia-Mata, J
    Vázquez, S
    De las Peñas, R
    Lorenzo, I
    Xaries, J
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S74 - S74
  • [43] Multicenter Phase II Study of Everolimus in Patients With Previously Treated Metastatic Gastric Cancer
    Doi, Toshihiko
    Muro, Kei
    Boku, Narikazu
    Yamada, Yasuhide
    Nishina, Tomohiro
    Takiuchi, Hiroya
    Komatsu, Yoshito
    Hamamoto, Yasuo
    Ohno, Nobutsugu
    Fujita, Yoshie
    Robson, Matthew
    Ohtsu, Atsushi
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (11) : 1904 - 1910
  • [44] Pemetrexed for previously treated patients with metastatic gastric cancer: a prospective phase II study
    Zhang, D. S.
    Jin, Y.
    Luo, H. Y.
    Wang, Z. Q.
    Qiu, M. Z.
    Wang, F. H.
    Li, Y. H.
    Xu, R. H.
    BRITISH JOURNAL OF CANCER, 2015, 112 (02) : 266 - 270
  • [45] Pemetrexed for previously treated patients with metastatic gastric cancer: a prospective phase II study
    D S Zhang
    Y Jin
    H Y Luo
    Z Q Wang
    M Z Qiu
    F H Wang
    Y H Li
    R H Xu
    British Journal of Cancer, 2015, 112 : 266 - 270
  • [46] A Phase II Study of Celecoxib With Irinotecan, 5-Fluorouracil, and Leucovorin in Patients With Previously Untreated Advanced or Metastatic Colorectal Cancer
    Chen, Emerson Y.
    Blanke, Charles D.
    Haller, Daniel G.
    Benson, Al B.
    Dragovich, Tomislav
    Lenz, Heinz-Josef
    Robles, Carlos
    Li, Hong
    Mori, Motomi
    Mattek, Nora
    Sanborn, Rachel E.
    Lopez, Charles D.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (12): : 1193 - 1198
  • [47] COMBINATION CHEMOTHERAPY OF ADVANCED COLORECTAL CANCER IN PATIENTS PREVIOUSLY TREATED WITH 5-FU
    MOAYERI, H
    EVANS, JT
    MITTELMAN, A
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 323 - 323
  • [48] Phase II trial of a biweekly regimen of fluorouracil and leucovorin plus irinotecan in patients with previously untreated advanced gastric cancer
    Rosati, G.
    Cordio, S.
    Caputo, G.
    Condorelli, S.
    Germano, D.
    Mattina, M.
    Amadio, P.
    Reggiardo, G.
    Manzione, L.
    ANNALS OF ONCOLOGY, 2007, 18 : 189 - 189
  • [49] Phase II study of irinotecan and mitomycin C in 5-fluorouracil-pretreated patients with advanced colorectal and gastric cancer
    Bamias, A
    Papamichael, D
    Syrigos, K
    Pavlidis, N
    JOURNAL OF CHEMOTHERAPY, 2003, 15 (03) : 275 - 281
  • [50] Phase II trial of a biweekly regimen of fluorouracil and leucovorin plus irinotecan in patients with previously untreated advanced gastric cancer
    Rosati, G.
    Cordio, S.
    Caputo, G.
    Condorelli, S.
    Germano, D.
    Mattina, M.
    Amadio, P.
    Reggiardo, G.
    Manzione, L.
    JOURNAL OF CHEMOTHERAPY, 2007, 19 (05) : 570 - 576
12345